During the past decade, Institut Curie Hopital conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Institut Curie Hopital" #1 sponsor was "UNICANCER" with 18 trials, followed by "European Organisation for Research and Treatment of Cancer - EORTC" with 7 trials sponsored, "Institut Curie" with 6 trials sponsored, "Assistance Publique - Hôpitaux de Paris" with 1 trials sponsored and "European Paediatric Soft Tissue Sarcoma Study Group" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Institut Curie Hopital" #1 collaborator was "National Cancer Institute, France" with 2 trials as a collaborator, "Anticancer Fund, Belgium" with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Australasian Leukaemia and Lymphoma Group" with 1 trials as a collaborator and "Australia and New Zealand Sarcoma Association" with 1 trials as a collaborator. Other collaborators include 16 different institutions and companies that were collaborators in the rest 26 trials.

According to Clinical.Site data, the most researched conditions in "Institut Curie Hopital" are "Breast Cancer" (14 trials), "Sarcoma" (5 trials), "Fallopian Tube Cancer" (2 trials), "Lymphoma" (2 trials) and "Ovarian Cancer" (2 trials). Many other conditions were trialed in "Institut Curie Hopital" in a lesser frequency.

Most popular intervention types in "Institut Curie Hopital" are "Drug" (30 trials), "Procedure" (15 trials), "Biological" (12 trials), "Other" (8 trials) and "Radiation" (5 trials). Other intervention types were less common.

The name of intervention was led by "docetaxel" (6 trials), "cyclophosphamide" (5 trials), "radiation therapy" (5 trials), "adjuvant therapy" (4 trials) and "bevacizumab" (4 trials). Other intervention names were less common.

The vast majority of trials in "Institut Curie Hopital" are 20 trials for "All" genders, 15 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Institut Curie Hopital". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 22 completed trials in Institut Curie Hopital, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Institut Curie Hopital, 3 "Phase 1" clinical trials were conducted, 18 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".